Peptide aptamers as new tools to modulate clathrin-mediated internalisation - inhibition of MT1-MMP internalisation

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Wickramasinghe, Rochana D ^a   Ferrigno, Paul K ^a,c   Roghi, Christian ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; MATRIX METALLOPROTEINASE 14; PEPTIDE APTAMER; PROTEINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 2; ADAPTOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL MIGRATION; CELL STRAIN MCF 7; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTERNALIZATION; MAMMAL CELL; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PLEIOTROPY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; RNA INTERFERENCE; CELL CULTURE; CELL MOTION; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

MAMMALIA;

ADAPTOR PROTEIN COMPLEX 2; AMINO ACID MOTIFS; APTAMERS, PEPTIDE; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CLATHRIN; ENDOCYTOSIS; HUMANS; MATRIX METALLOPROTEINASE 14; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SELEX APTAMER TECHNIQUE;

EID: 77954783466     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-58     Document Type: Article

References (62)

1. Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 1996, 380:548-550. 10.1038/380548a0, 8606778.
2. Binz HK, Amstutz P, Pluckthun A. Engineering novel binding proteins from nonimmunoglobulin domains. Nat Biotechnol 2005, 23:1257-1268. 10.1038/nbt1127, 16211069.
3. Kolonin MG, Finley RL. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers. Proc Natl Acad Sci USA 1998, 95:14266-14271. 10.1073/pnas.95.24.14266, 24362, 9826689.
4. Blum JH, Dove SL, Hochschild A, Mekalanos JJ. Isolation of peptide aptamers that inhibit intracellular processes. Proc Natl Acad Sci USA 2000, 97:2241-2246. 10.1073/pnas.040573397, 15785, 10688899.
5. Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F. Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci USA 2000, 97:6693-6697. 10.1073/pnas.110538897, 18705, 10829072.
6. Nauenburg S, Zwerschke W, Jansen-Durr P. Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV-16 E7 oncoprotein. FASEB J 2001, 15:592-594.
7. Buerger C, Nagel-Wolfrum K, Kunz C, Wittig I, Butz K, Hoppe-Seyler F, Groner B. Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells. J Biol Chem 2003, 278:37610-37621. 10.1074/jbc.M301629200, 12842895.
8. Nagel-Wolfrum K, Buerger C, Wittig I, Butz K, Hoppe-Seyler F, Groner B. The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Mol Cancer Res 2004, 2:170-182.
9. Chattopadhyay A, Tate SA, Beswick RW, Wagner SD, Ko Ferrigno P. A peptide aptamer to antagonize BCL-6 function. Oncogene 2006, 25:2223-2233. 10.1038/sj.onc.1209252, 16331266.
10. Cohen BA, Colas P, Brent R. An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc Natl Acad Sci USA 1998, 95:14272-14277. 10.1073/pnas.95.24.14272, 24363, 9826690.
11. Fabbrizio E, Le Cam L, Polanowska J, Kaczorek M, Lamb N, Brent R, Sardet C. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene 1999, 18:4357-4363. 10.1038/sj.onc.1202825, 10439043.
12. Bottger A, Bottger V, Sparks A, Liu WL, Howard SF, Lane DP. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol 1997, 7:860-869. 10.1016/S0960-9822(06)00374-5, 9382809.
13. Nouvion AL, Thibaut J, Lohez OD, Venet S, Colas P, Gillet G, Lalle P. Modulation of Nr-13 antideath activity by peptide aptamers. Oncogene 2007, 26(5):701-10. 10.1038/sj.onc.1209832, 16909120.
14. Barbolina MV, Stack MS. Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. Semin Cell Dev Biol 2008, 19:24-33. 10.1016/j.semcdb.2007.06.008, 2685078, 17702616.
15. Zucker S, Pei D, Cao J, Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 2003, 54:1-74. full_text, 12696745.
16. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996, 271:17119-17123. 10.1074/jbc.271.29.17124, 8663332.
17. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996, 271:17124-17131. 10.1074/jbc.271.29.17124, 8663255.
18. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001, 153:893-904. 10.1083/jcb.153.5.893, 2174329, 11381077.
19. Belkin AM, Zemskov EA, Hang J, Akimov SS, Sikora S, Strongin AY. Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis. Biochemistry (Mosc) 2004, 43:11760-11769.
20. Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI, Strongin AY. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 2002, 277:7377-7385. 10.1074/jbc.M109580200, 11741954.
21. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 2003, 278:40764-40770. 10.1074/jbc.M306736200, 12904296.
22. Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H. MT1-MMP: a tethered collagenase. J Cell Physiol 2004, 200:11-19. 10.1002/jcp.20065, 15137053.
23. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006, 206:1-8. 10.1002/jcp.20431, 15920734.
24. Genis L, Galvez BG, Gonzalo P, Arroyo AG. MT1-MMP: universal or particular player in angiogenesis?. Cancer Metastasis Rev 2006, 25:77-86. 10.1007/s10555-006-7891-z, 16680574.
25. Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S, et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004, 167:769-781. 10.1083/jcb.200408028, 2172570, 15557125.
26. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114:33-45. 10.1016/S0092-8674(03)00513-0, 12859896.
27. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 2003, 194:1-11. 10.1016/S0304-3835(02)00699-7, 12706853.
28. Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002, 99:157-166. 10.1002/ijc.10329, 11979428.
29. Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 2003, 22:8716-8722. 10.1038/sj.onc.1206962, 14647466.
30. Lehti K, Valtanen H, Wickstrom SA, Lohi J, Keski-Oja J. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 2000, 275:15006-15013. 10.1074/jbc.M910220199, 10748199.
31. Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 2001, 155:1345-1356. 10.1083/jcb.200108112, 2199326, 11756481.
32. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 2001, 98:13693-13698. 10.1073/pnas.241293698, 61103, 11698655.
33. Anilkumar N, Uekita T, Couchman JR, Nagase H, Seiki M, Itoh Y. Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration. FASEB J 2005, 19:1326-1328.
34. D'Alessio S, Ferrari G, Cinnante K, Scheerer W, Galloway AC, Roses DF, Rozanov DV, Remacle AG, Oh ES, Shiryaev SA, et al. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J Biol Chem 2008, 283:87-99. 10.1074/jbc.M705492200, 17991754.
35. Uekita T, Gotoh I, Kinoshita T, Itoh Y, Sato H, Shiomi T, Okada Y, Seiki M. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors. J Biol Chem 2004, 279:12734-12743. 10.1074/jbc.M309957200, 14718544.
36. Rozanov DV, Ghebrehiwet B, Ratnikov B, Monosov EZ, Deryugina EI, Strongin AY. The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein. FEBS Lett 2002, 527:51-57. 10.1016/S0014-5793(02)03153-8, 12220632.
37. Wang X, Ma D, Keski-Oja J, Pei D. Co-recycling of MT1-MMP and MT3-MMP through the trans-Golgi network. Identification of DKV582 as a recycling signal. J Biol Chem 2004, 279:9331-9336. 10.1074/jbc.M312369200, 14665622.
38. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, Gingras D, Beliveau R. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem 2004, 279:52132-52140. 10.1074/jbc.M409617200, 15466865.
39. Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Quigley JP, Strongin AY. Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem 2001, 276:25705-25714. 10.1074/jbc.M007921200, 11335709.
40. Sounni NE, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E, Galvez BG, Gilles C, Frankenne F, Murphy G, et al. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem 2004, 279:13564-13574. 10.1074/jbc.M307688200, 14729679.
41. Nyalendo C, Michaud M, Beaulieu E, Roghi C, Murphy G, Gingras D, Beliveau R. Src-dependent Phosphorylation of Membrane Type I Matrix Metalloproteinase on Cytoplasmic Tyrosine 573: Role in endothelial and tumour cell migration. J Biol Chem 2007, 282:15690-15699. 10.1074/jbc.M608045200, 17389600.
42. Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B, Beliveau R. Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 2001, 507:231-236. 10.1016/S0014-5793(01)02985-4, 11684104.
43. Rozanov DV, Deryugina EI, Monosov EZ, Marchenko ND, Strongin AY. Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. Exp Cell Res 2004, 293:81-95. 10.1016/j.yexcr.2003.10.006, 14729059.
44. Finley RL, Brent R. Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. Proc Natl Acad Sci USA 1994, 91:12980-12984. 10.1073/pnas.91.26.12980, 45564, 7809159.
45. Woodman R, Yeh JT, Laurenson S, Ferrigno PK. Design and validation of a neutral protein scaffold for the presentation of peptide aptamers. J Mol Biol 2005, 352:1118-1133. 10.1016/j.jmb.2005.08.001, 16139842.
46. Deryugina EI, Bourdon MA, Jungwirth K, Smith JW, Strongin AY. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer 2000, 86:15-23. 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B, 10728589.
47. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 2002, 21:3949-3959. 10.1093/emboj/cdf411, 126155, 12145196.
48. Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 2002, 16:555-564. 10.1096/fj.01-0790com, 11919158.
49. Remacle A, Murphy G, Roghi C. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci 2003, 116:3905-3916. 10.1242/jcs.00710, 12915589.
50. d'Ortho MP, Stanton H, Butler M, Atkinson SJ, Murphy G, Hembry RM. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett 1998, 421:159-164. 10.1016/S0014-5793(97)01555-X, 9468298.
51. Yana I, Weiss SJ. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 2000, 11:2387-2401. 14927, 10888676.
52. Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Bahou WF, Zucker S. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem 2004, 279:14129-14139. 10.1074/jbc.M312120200, 14729674.
53. Galvez BG, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo AG. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell 2004, 15:678-687. 10.1091/mbc.E03-07-0516, 329288, 14657245.
54. Lavie Y, Fiucci G, Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 1998, 273:32380-32383. 10.1074/jbc.273.49.32380, 9829965.
55. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998, 16:1391-1397. 10.1038/sj.onc.1201661, 9525738.
56. Engelman JA, Zhang XL, Lisanti MP. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 1999, 448:221-230. 10.1016/S0014-5793(99)00365-8, 10218480.
57. Hurlstone AF, Reid G, Reeves JR, Fraser J, Strathdee G, Rahilly M, Parkinson EK, Black DM. Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 1999, 18:1881-1890. 10.1038/sj.onc.1202491, 10086342.
58. Fiucci G, Ravid D, Reich R, Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 2002, 21:2365-2375. 10.1038/sj.onc.1205300, 11948420.
59. de Chassey B, Mikaelian I, Mathieu AL, Bickle M, Olivier D, Negre D, Cosset FL, Rudkin BB, Colas P. An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity. Mol Cell Proteomics 2007, 6:451-459.
60. Gyuris J, Golemis E, Chertkov H, Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 1993, 75:791-803. 10.1016/0092-8674(93)90498-F, 8242750.
61. Colas P, Cohen B, Ko Ferrigno P, Silver PA, Brent R. Targeted modification and transportation of cellular proteins. Proc Natl Acad Sci USA 2000, 97:13720-13725. 10.1073/pnas.97.25.13720, 17642, 11106396.
62. Raucher D, Sheetz MP. Membrane expansion increases endocytosis rate during mitosis. J Cell Biol 1999, 144:497-506. 10.1083/jcb.144.3.497, 2132908, 9971744.